These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

433 related items for PubMed ID: 19351839

  • 21. Rosiglitazone promotes tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by reactive oxygen species-mediated up-regulation of death receptor 5 and down-regulation of c-FLIP.
    Kim YH, Jung EM, Lee TJ, Kim SH, Choi YH, Park JW, Park JW, Choi KS, Kwon TK.
    Free Radic Biol Med; 2008 Mar 15; 44(6):1055-68. PubMed ID: 18164688
    [Abstract] [Full Text] [Related]

  • 22. Butein sensitizes human hepatoma cells to TRAIL-induced apoptosis via extracellular signal-regulated kinase/Sp1-dependent DR5 upregulation and NF-kappaB inactivation.
    Moon DO, Kim MO, Choi YH, Kim GY.
    Mol Cancer Ther; 2010 Jun 15; 9(6):1583-95. PubMed ID: 20515942
    [Abstract] [Full Text] [Related]

  • 23. OSMI-1 Enhances TRAIL-Induced Apoptosis through ER Stress and NF-κB Signaling in Colon Cancer Cells.
    Lee SJ, Lee DE, Choi SY, Kwon OS.
    Int J Mol Sci; 2021 Oct 14; 22(20):. PubMed ID: 34681736
    [Abstract] [Full Text] [Related]

  • 24. Proteasome inhibitors enhance TRAIL-induced apoptosis through the intronic regulation of DR5: involvement of NF-kappa B and reactive oxygen species-mediated p53 activation.
    Chen JJ, Chou CW, Chang YF, Chen CC.
    J Immunol; 2008 Jun 15; 180(12):8030-9. PubMed ID: 18523266
    [Abstract] [Full Text] [Related]

  • 25. Nuclear factor-kappaB maintains TRAIL resistance in human pancreatic cancer cells.
    Khanbolooki S, Nawrocki ST, Arumugam T, Andtbacka R, Pino MS, Kurzrock R, Logsdon CD, Abbruzzese JL, McConkey DJ.
    Mol Cancer Ther; 2006 Sep 15; 5(9):2251-60. PubMed ID: 16985059
    [Abstract] [Full Text] [Related]

  • 26. Down-regulation of Cbl-b by bufalin results in up-regulation of DR4/DR5 and sensitization of TRAIL-induced apoptosis in breast cancer cells.
    Yan S, Qu X, Xu C, Zhu Z, Zhang L, Xu L, Song N, Teng Y, Liu Y.
    J Cancer Res Clin Oncol; 2012 Aug 15; 138(8):1279-89. PubMed ID: 22447040
    [Abstract] [Full Text] [Related]

  • 27. Role of autophagy in chemoresistance: regulation of the ATM-mediated DNA-damage signaling pathway through activation of DNA-PKcs and PARP-1.
    Yoon JH, Ahn SG, Lee BH, Jung SH, Oh SH.
    Biochem Pharmacol; 2012 Mar 15; 83(6):747-57. PubMed ID: 22226932
    [Abstract] [Full Text] [Related]

  • 28. Goniothalamin enhances TRAIL-induced apoptosis in colorectal cancer cells through DR5 upregulation and cFLIP downregulation.
    Sophonnithiprasert T, Nilwarangkoon S, Nakamura Y, Watanapokasin R.
    Int J Oncol; 2015 Dec 15; 47(6):2188-96. PubMed ID: 26499766
    [Abstract] [Full Text] [Related]

  • 29. The role of ATM and 53BP1 as predictive markers in cervical cancer.
    Roossink F, Wieringa HW, Noordhuis MG, ten Hoor KA, Kok M, Slagter-Menkema L, Hollema H, de Bock GH, Pras E, de Vries EG, de Jong S, van der Zee AG, Schuuring E, Wisman GB, van Vugt MA.
    Int J Cancer; 2012 Nov 01; 131(9):2056-66. PubMed ID: 22323184
    [Abstract] [Full Text] [Related]

  • 30. Suppressing the high-level expression and function of ATM in advanced-stage melanomas does not sensitize the cells to ionizing radiation.
    Moschos SJ, Dodd NR, Jukic DM, Fayewicz SL, Wang X, Becker D.
    Cancer Biol Ther; 2009 Oct 01; 8(19):1815-25. PubMed ID: 19684476
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. ATM inhibitor KU-55933 increases the TMZ responsiveness of only inherently TMZ sensitive GBM cells.
    Nadkarni A, Shrivastav M, Mladek AC, Schwingler PM, Grogan PT, Chen J, Sarkaria JN.
    J Neurooncol; 2012 Dec 01; 110(3):349-57. PubMed ID: 23054561
    [Abstract] [Full Text] [Related]

  • 33. Short-hairpin RNA-induced suppression of adenine nucleotide translocase-2 in breast cancer cells restores their susceptibility to TRAIL-induced apoptosis by activating JNK and modulating TRAIL receptor expression.
    Jang JY, Jeon YK, Choi Y, Kim CW.
    Mol Cancer; 2010 Sep 28; 9():262. PubMed ID: 20875141
    [Abstract] [Full Text] [Related]

  • 34. Cl-IB-MECA enhances TRAIL-induced apoptosis via the modulation of NF-kappaB signalling pathway in thyroid cancer cells.
    Morello S, Sorrentino R, Porta A, Forte G, Popolo A, Petrella A, Pinto A.
    J Cell Physiol; 2009 Nov 28; 221(2):378-86. PubMed ID: 19562684
    [Abstract] [Full Text] [Related]

  • 35. Withaferin A sensitizes TRAIL-induced apoptosis through reactive oxygen species-mediated up-regulation of death receptor 5 and down-regulation of c-FLIP.
    Lee TJ, Um HJ, Min do S, Park JW, Choi KS, Kwon TK.
    Free Radic Biol Med; 2009 Jun 15; 46(12):1639-49. PubMed ID: 19345731
    [Abstract] [Full Text] [Related]

  • 36. Ataxia telangiectasia mutated impacts insulin-like growth factor 1 signalling in skeletal muscle.
    Ching JK, Luebbert SH, Collins RL, Zhang Z, Marupudi N, Banerjee S, Hurd RD, Ralston L, Fisher JS.
    Exp Physiol; 2013 Feb 15; 98(2):526-35. PubMed ID: 22941977
    [Abstract] [Full Text] [Related]

  • 37. Bortezomib sensitizes malignant human glioma cells to TRAIL, mediated by inhibition of the NF-{kappa}B signaling pathway.
    Jane EP, Premkumar DR, Pollack IF.
    Mol Cancer Ther; 2011 Jan 15; 10(1):198-208. PubMed ID: 21220502
    [Abstract] [Full Text] [Related]

  • 38. Dissecting the roles of DR4, DR5 and c-FLIP in the regulation of geranylgeranyltransferase I inhibition-mediated augmentation of TRAIL-induced apoptosis.
    Chen S, Fu L, Raja SM, Yue P, Khuri FR, Sun SY.
    Mol Cancer; 2010 Jan 29; 9():23. PubMed ID: 20113484
    [Abstract] [Full Text] [Related]

  • 39. The cellular ataxia telangiectasia-mutated kinase promotes epstein-barr virus lytic reactivation in response to multiple different types of lytic reactivation-inducing stimuli.
    Hagemeier SR, Barlow EA, Meng Q, Kenney SC.
    J Virol; 2012 Dec 29; 86(24):13360-70. PubMed ID: 23015717
    [Abstract] [Full Text] [Related]

  • 40. Down-regulation of EBV-LMP1 radio-sensitizes nasal pharyngeal carcinoma cells via NF-κB regulated ATM expression.
    Ma X, Yang L, Xiao L, Tang M, Liu L, Li Z, Deng M, Sun L, Cao Y.
    PLoS One; 2011 Dec 29; 6(11):e24647. PubMed ID: 22096476
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.